133 related articles for article (PubMed ID: 9154967)
1. Dihydro(alkylthio)(naphthylmethyl)oxopyrimidines: novel non-nucleoside reverse transcriptase inhibitors of the S-DABO series.
Mai A; Artico M; Sbardella G; Quartarone S; Massa S; Loi AG; De Montis A; Scintu F; Putzolu M; La Colla P
J Med Chem; 1997 May; 40(10):1447-54. PubMed ID: 9154967
[TBL] [Abstract][Full Text] [Related]
2. Computer-aided design, synthesis, and anti-HIV-1 activity in vitro of 2-alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as novel potent non-nucleoside reverse transcriptase inhibitors, also active against the Y181C variant.
Ragno R; Mai A; Sbardella G; Artico M; Massa S; Musiu C; Mura M; Marturana F; Cadeddu A; La Colla P
J Med Chem; 2004 Feb; 47(4):928-34. PubMed ID: 14761194
[TBL] [Abstract][Full Text] [Related]
3. 5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3, 4-dihydropyrimidin-4(3H)-ones: novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives.
Mai A; Artico M; Sbardella G; Massa S; Novellino E; Greco G; Loi AG; Tramontano E; Marongiu ME; La Colla P
J Med Chem; 1999 Feb; 42(4):619-27. PubMed ID: 10052969
[TBL] [Abstract][Full Text] [Related]
4. Non-nucleoside HIV reverse transcriptase inhibitors, Part 6[1]: synthesis and anti-HIV activity of novel 2-[(arylcarbonylmethyl)thio]-6-arylthio DABO analogues.
Sun GF; Kuang YY; Chen FE; De Clercq E; Balzarini J; Pannecouque C
Arch Pharm (Weinheim); 2005 Oct; 338(10):457-61. PubMed ID: 16211654
[TBL] [Abstract][Full Text] [Related]
5. Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues.
Wang Y; Chen FE; Balzarini J; De Clercq E; Pannecouque C
Chem Biodivers; 2008 Jan; 5(1):168-76. PubMed ID: 18205120
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological properties of novel 2-aminopyrimidin-4(3H)-ones highly potent against HIV-1 mutant strains.
Mai A; Artico M; Rotili D; Tarantino D; Clotet-Codina I; Armand-Ugón M; Ragno R; Simeoni S; Sbardella G; Nawrozkij MB; Samuele A; Maga G; Esté JA
J Med Chem; 2007 Nov; 50(22):5412-24. PubMed ID: 17910429
[TBL] [Abstract][Full Text] [Related]
7. 5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones, a new series of potent, broad-spectrum non-nucleoside reverse transcriptase inhibitors belonging to the DABO family.
Mai A; Artico M; Ragno R; Sbardella G; Massa S; Musiu C; Mura M; Marturana F; Cadeddu A; Maga G; La Colla P
Bioorg Med Chem; 2005 Mar; 13(6):2065-77. PubMed ID: 15727860
[TBL] [Abstract][Full Text] [Related]
8. 5-Alkyl-2-[(aryl and alkyloxylcarbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones as an unique HIV reverse transcriptase inhibitors of S-DABO series.
He Y; Chen F; Sun G; Wang Y; De Clercq E; Balzarini J; Pannecouque C
Bioorg Med Chem Lett; 2004 Jun; 14(12):3173-6. PubMed ID: 15149669
[TBL] [Abstract][Full Text] [Related]
9. Dihydro-alkylthio-benzyl-oxopyrimidines as inhibitors of reverse transcriptase: synthesis and rationalization of the biological data on both wild-type enzyme and relevant clinical mutants.
Mugnaini C; Alongi M; Togninelli A; Gevariya H; Brizzi A; Manetti F; Bernardini C; Angeli L; Tafi A; Bellucci L; Corelli F; Massa S; Maga G; Samuele A; Facchini M; Clotet-Codina I; Armand-Ugón M; Esté JA; Botta M
J Med Chem; 2007 Dec; 50(26):6580-95. PubMed ID: 18052319
[TBL] [Abstract][Full Text] [Related]
10. Nonnucleoside HIV-1 reverse transcriptase inhibitors; part 3. Synthesis and antiviral activity of 5-alkyl-2-[(aryl and alkyloxyl-carbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones.
He Y; Chen F; Yu X; Wang Y; De Clercq E; Balzarini J; Pannecouque C
Bioorg Chem; 2004 Dec; 32(6):536-48. PubMed ID: 15530994
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of novel C5 halogen-functionalized S-DABO as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
Qin H; Liu C; Guo Y; Wang R; Zhang J; Ma L; Zhang Z; Wang X; Cui Y; Liu J
Bioorg Med Chem; 2010 May; 18(9):3231-7. PubMed ID: 20371182
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro anti-HIV evaluation of a new series of 6-arylmethyl-substituted S-DABOs as potential non-nucleoside HIV-1 reverse transcriptase inhibitors.
Wang YP; Chen FE; De Clercq E; Balzarini J; Pannecouque C
Eur J Med Chem; 2009 Mar; 44(3):1016-23. PubMed ID: 18692274
[TBL] [Abstract][Full Text] [Related]
13. The design and synthesis of 9-phenylcyclohepta[d]pyrimidine-2,4-dione derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase.
Wang X; Lou Q; Guo Y; Xu Y; Zhang Z; Liu J
Org Biomol Chem; 2006 Sep; 4(17):3252-8. PubMed ID: 17036113
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-HIV-1 activity evaluation of 5-alkyl-2-alkylthio-6-(arylcarbonyl or alpha-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Ji L; Chen FE; De Clercq E; Balzarini J; Pannecouque C
J Med Chem; 2007 Apr; 50(8):1778-86. PubMed ID: 17381078
[TBL] [Abstract][Full Text] [Related]
15. Novel 1,3-dihydro-benzimidazol-2-ones and their analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Monforte AM; Logoteta P; De Luca L; Iraci N; Ferro S; Maga G; De Clercq E; Pannecouque C; Chimirri A
Bioorg Med Chem; 2010 Feb; 18(4):1702-10. PubMed ID: 20097079
[TBL] [Abstract][Full Text] [Related]
16. A versatile route to C-6 arylmethyl-functionalized S-DABO and related analogues.
Radi M; Contemori L; Castagnolo D; Spinosa R; Esté JA; Massa S; Botta M
Org Lett; 2007 Aug; 9(16):3157-60. PubMed ID: 17625879
[TBL] [Abstract][Full Text] [Related]
17. Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activity.
Manetti F; Esté JA; Clotet-Codina I; Armand-Ugón M; Maga G; Crespan E; Cancio R; Mugnaini C; Bernardini C; Togninelli A; Carmi C; Alongi M; Petricci E; Massa S; Corelli F; Botta M
J Med Chem; 2005 Dec; 48(25):8000-8. PubMed ID: 16335924
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Mai A; Sbardella G; Artico M; Ragno R; Massa S; Novellino E; Greco G; Lavecchia A; Musiu C; La Colla M; Murgioni C; La Colla P; Loddo R
J Med Chem; 2001 Aug; 44(16):2544-54. PubMed ID: 11472208
[TBL] [Abstract][Full Text] [Related]
19. A multidisciplinary approach for the identification of novel HIV-1 non-nucleoside reverse transcriptase inhibitors: S-DABOCs and DAVPs.
Radi M; Falciani C; Contemori L; Petricci E; Maga G; Samuele A; Zanoli S; Terrazas M; Castria M; Togninelli A; Esté JA; Clotet-Codina I; Armand-Ugón M; Botta M
ChemMedChem; 2008 Apr; 3(4):573-93. PubMed ID: 18081133
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-HIV-1 activity of thio analogues of dihydroalkoxybenzyloxopyrimidines.
Mai A; Artico M; Sbardella G; Massa S; Loi AG; Tramontano E; Scano P; La Colla P
J Med Chem; 1995 Aug; 38(17):3258-63. PubMed ID: 7650679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]